Capturing Pharmaceutical Emerging Markets with Data

|

article image
Developing a drug and introducing it to the marketplace is extremely expensive and time-consuming. The average cost to develop a new drug is between four and 11 billion dollars, and it takes 12 years from discovery to market. Fewer than one in 10 drugs that start human clinical trials make it to market. Given the enormous cost to develop a new drug, mature pharma markets are stagnating.

Spotlight

Qualitest Pharmaceuticals

Since 1983, the people of Qualitest have dedicated themselves to researching, manufacturing and delivering affordable, high-quality generic pharmaceuticals. Headquartered in Huntsville, Alabama, the company is now ranked in the industry top ten. With manufacturing facilities in Charlotte, North Carolina and Huntsville, Alabama the company has a portfolio exceeding 700 products.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | March 16, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 16, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | March 16, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

Qualitest Pharmaceuticals

Since 1983, the people of Qualitest have dedicated themselves to researching, manufacturing and delivering affordable, high-quality generic pharmaceuticals. Headquartered in Huntsville, Alabama, the company is now ranked in the industry top ten. With manufacturing facilities in Charlotte, North Carolina and Huntsville, Alabama the company has a portfolio exceeding 700 products.

Events